• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死的当前治疗方法综述

Review of Current Management of Myocardial Infarction.

作者信息

Saha Trisha, Soliman-Aboumarie Hatem

机构信息

Bloomsbury Campus, University College London Medical School, 74 Huntley St, London WC1E 6DE, UK.

Department of Anaesthetics and Cardiothoracic Critical Care, Harefield Hospital, Hill End Road, Uxbridge, London UB9 6JH, UK.

出版信息

J Clin Med. 2025 Sep 4;14(17):6241. doi: 10.3390/jcm14176241.

DOI:10.3390/jcm14176241
PMID:40944000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12429806/
Abstract

Myocardial infarction (MI), commonly known as a heart attack, remains a leading cause of morbidity and mortality worldwide. It arises from a sudden cessation of coronary blood flow, most often due to plaque rupture and subsequent thrombus formation. Over the years, significant advances in the understanding, diagnosis, and treatment of MI have transformed patient outcomes. This review explores the current approaches to the management of myocardial infarction, highlighting evidence-based practices, recent advancements, and ongoing challenges in optimising care across various healthcare settings.

摘要

心肌梗死(MI),通常被称为心脏病发作,仍然是全球发病和死亡的主要原因。它是由于冠状动脉血流突然中断引起的,最常见的原因是斑块破裂和随后的血栓形成。多年来,在心肌梗死的认识、诊断和治疗方面取得的重大进展改变了患者的预后。本综述探讨了目前心肌梗死的管理方法,强调了循证实践、最新进展以及在优化各种医疗环境中的护理方面持续存在的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/41483c3a9ba5/jcm-14-06241-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/e1a62f38fc62/jcm-14-06241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/9f4303425cb7/jcm-14-06241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/c0af127aa8a4/jcm-14-06241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/d1df8b2f3654/jcm-14-06241-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/95f822d1eaf8/jcm-14-06241-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/41483c3a9ba5/jcm-14-06241-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/e1a62f38fc62/jcm-14-06241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/9f4303425cb7/jcm-14-06241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/c0af127aa8a4/jcm-14-06241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/d1df8b2f3654/jcm-14-06241-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/95f822d1eaf8/jcm-14-06241-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1efc/12429806/41483c3a9ba5/jcm-14-06241-g006.jpg

相似文献

1
Review of Current Management of Myocardial Infarction.急性心肌梗死的当前治疗方法综述
J Clin Med. 2025 Sep 4;14(17):6241. doi: 10.3390/jcm14176241.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Assessing angiographic results of saline autotransfusion and thrombus aspiration in STEMI patients.评估ST段抬高型心肌梗死患者自体盐水输注及血栓抽吸的血管造影结果。
Future Cardiol. 2025 Mar;21(4):237-243. doi: 10.1080/14796678.2025.2472581. Epub 2025 Mar 4.
4
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
5
Exercise-based rehabilitation for coronary heart disease.基于运动的冠心病康复治疗
Cochrane Database Syst Rev. 2000(4):CD001800. doi: 10.1002/14651858.CD001800.
6
Identification and Management Strategies for Intracoronary High Thrombus Burden in Patients With STEMI: A Practical Experience and Literature Review.ST段抬高型心肌梗死患者冠状动脉内高血栓负荷的识别与管理策略:实践经验与文献综述
Rev Cardiovasc Med. 2025 Jul 30;26(7):37466. doi: 10.31083/RCM37466. eCollection 2025 Jul.
7
30-year trends in incidence of acute STEMI and NSTEMI in the Belgian Province of Luxembourg. A long-term follow-up of the MONICA-BELLUX registry.比利时卢森堡省急性ST段抬高型心肌梗死和非ST段抬高型心肌梗死发病率的30年趋势。MONICA-BELLUX注册研究的长期随访。
Acta Cardiol. 2025 Sep;80(7):709-720. doi: 10.1080/00015385.2025.2524233. Epub 2025 Jul 17.
8
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
9
Ophthalmia Neonatorum新生儿眼炎
10
Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.支架时代不稳定型心绞痛和非ST段抬高型心肌梗死的常规侵入性策略与选择性侵入性策略
Cochrane Database Syst Rev. 2016 May 26;2016(5):CD004815. doi: 10.1002/14651858.CD004815.pub4.

本文引用的文献

1
Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomized controlled trials.SGLT2抑制剂在心血管疾病全谱中预防心房颤动:一项随机对照试验的荟萃分析
Eur Heart J Cardiovasc Pharmacother. 2025 Aug 12;11(5):441-450. doi: 10.1093/ehjcvp/pvaf040.
2
Artificial Intelligence and Its Role in the Diagnosis and Prediction of Adverse Events in Acute Coronary Syndrome: A Narrative Review of the Literature.人工智能及其在急性冠状动脉综合征不良事件诊断和预测中的作用:文献综述
Life (Basel). 2025 Mar 21;15(4):515. doi: 10.3390/life15040515.
3
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure.
钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂在心力衰竭之外的心血管治疗靶点。
Pharmacol Ther. 2025 Jun;270:108861. doi: 10.1016/j.pharmthera.2025.108861. Epub 2025 Apr 15.
4
Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.更正:《2025年美国心脏病学会/美国心脏协会/美国急诊医师学会/美国急诊医疗服务医师学会/心血管造影和介入学会急性冠状动脉综合征患者管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告》
Circulation. 2025 Apr;151(13):e865. doi: 10.1161/CIR.0000000000001328. Epub 2025 Mar 31.
5
Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.非ST段抬高型心肌梗死患者中4a型心肌梗死和围手术期心肌损伤的预后相关性
Circulation. 2025 Mar 18;151(11):760-772. doi: 10.1161/CIRCULATIONAHA.124.070729. Epub 2025 Feb 19.
6
IMPELLA COMPARED TO VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION IN CARDIOGENIC SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROPENSITY SCORE-MATCHED STUDIES.在心源性休克中,Impella与静脉-动脉体外膜肺氧合的比较:倾向评分匹配研究的系统评价和荟萃分析
Shock. 2025 Apr 1;63(4):512-519. doi: 10.1097/SHK.0000000000002540. Epub 2025 Feb 7.
7
Impact of In-Hospital Bleeding on Postdischarge Therapies and Prognosis in Acute Coronary Syndromes.院内出血对急性冠状动脉综合征出院后治疗及预后的影响
J Cardiovasc Pharmacol. 2025 May 1;85(5):322-328. doi: 10.1097/FJC.0000000000001678.
8
Postmyocardial Infarction Ventricular Aneurysm: JACC Focus Seminar 5/5.心肌梗死后室壁瘤:美国心脏病学会焦点研讨会 5/5.
J Am Coll Cardiol. 2024 May 14;83(19):1917-1935. doi: 10.1016/j.jacc.2024.02.044.
9
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.达格列净与糖尿病或心力衰竭无关的心肌梗死。
NEJM Evid. 2024 Feb;3(2):EVIDoa2300286. doi: 10.1056/EVIDoa2300286. Epub 2023 Nov 11.
10
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.心肌梗死合并贫血的限制性输血或宽松性输血策略。
N Engl J Med. 2023 Dec 28;389(26):2446-2456. doi: 10.1056/NEJMoa2307983. Epub 2023 Nov 11.